Agios Pharmaceuticals Inc. sell StockNews.com
Start price
15.02.25
/
50%
€31.60
Target price
15.02.26
-
Performance (%)
-26.58%
Price
30.12.25
€23.20
Summary
This prediction is currently active. The prediction for Agios Pharmaceuticals Inc. shows a convincing performance of -26.58%. This prediction currently runs until 15.02.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | 10.476% | 10.476% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by StockNews_com for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by StockNews_com for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€38.80
03.07.24
03.07.24
-
03.07.25
03.07.25
-21.65%
04.07.25
04.07.25
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.20
10.03.23
10.03.23
-
10.03.24
10.03.24
38.61%
11.03.24
11.03.24